Identifying patients with alpha1-antitrypsin deficiency | Alpha-1 symptoms and diagnosis

Watch this video to learn why genetic screening for alpha-1 in all patients with COPD is recommended, regardless of age, smoking history, or FEV1.[1-5] It’s difficult to detect alpha-1 without genetic testing because its symptoms are similar to COPD and asthma.[1,2,6] A patient with alpha-1 cannot be identified by symptoms or medical examination alone. Genetic testing is required to diagnose alpha-1.[7] You can learn more at https://bit.ly/3zWFkP7 More information about alpha-1: https://bit.ly/3ndOTFR Alpha-1 screening guidelines: https://bit.ly/3BRB4B6 Order free AlphaID™ screening kits: https://bit.ly/38OVQVH References: [1] World Health Organization. α1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397-415. [2] American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900. [3] Willie KM, Sharma NS. About alpha-1 antitrypsin deficiency. CHEST Foundation website. https://foundation.chestnet.org/lung-.... Accessed July 12, 2021. [4] Sandhaus RA, Turino G, Brantly ML, et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis. 2016;3(3):668-682. [5] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 Report. [6] Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3):1179-1186. [7] Lung disease. Alpha-1 Foundation website. https://www.alpha1.org/newly-diagnose.... Accessed July 12, 2021.